Aoboer Technology (Xiamen) Co., Ltd. – Trademark Portfolio

Entity Type: 16

Aoboer Technology (Xiamen) Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include YOBETT. The owner is based in Xiamen.

6/F No. 56 Fanghu Indus. Park

Huli Dist.

Xiamen 361000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

YOBETT
YOBETT
Registered 2025
YOBETT
YOBETT
Cancelled 2016

Trademark Classifications

Aoboer Technology (Xiamen) Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Aoboer Technology (Xiamen) Co., Ltd. have?

Aoboer Technology (Xiamen) Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does Aoboer Technology (Xiamen) Co., Ltd. file in?

Aoboer Technology (Xiamen) Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Aoboer Technology (Xiamen) Co., Ltd.'s most well-known trademarks?

Aoboer Technology (Xiamen) Co., Ltd.'s registered trademark portfolio includes well-known marks such as YOBETT. These are among 1 currently registered trademark in the portfolio.

What is Aoboer Technology (Xiamen) Co., Ltd.'s trademark registration success rate?

Aoboer Technology (Xiamen) Co., Ltd. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.